UniQure Says FDA Accepts Application for Huntington’s Gene Therapy
UniQure said the FDA accepted an application for its potential Huntington’s disease gene therapy.
Story updates
01:06:06 PM UTC
SquawkNews
Dutch gene therapy developer uniQure NASDAQ:QURE said on Monday the US FDA had accepted its application for its Huntington's disease treatment and would decide on the drug by May 1, 2027.US-listed shares of the company were up 2.5% in premarket trading.Here are some details